CNETWhat to Know About Weight-Loss Drugs and Sleep ApneaApr 18Jessica RendallBy Jessica Rendallmore_vert
Investors | Eli Lilly and CompanyTirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and ...Apr 17more_vert
CNBCEli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trialsApr 17Annika Kim ConstantinoBy Annika Kim Constantinomore_vert
The New York TimesSleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly ReportsApr 18Gina KolataBy Gina Kolatamore_vert
STATZepbound effective in obstructive sleep apnea trials - STATApr 17Elaine ChenBy Elaine Chenmore_vert
ReutersLilly's weight-loss drug reduces sleep apnea severity in late-stage trialsApr 17Bhanvi SatijaBy Bhanvi Satijamore_vert
The HillWeight-loss drug linked to sleep apnea reduction: ResearchApr 17Miranda NazzaroBy Miranda Nazzaromore_vert
NBC NewsEli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company saysApr 17Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
CNNWeight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker saysApr 17Jen ChristensenBy Jen Christensenmore_vert